Showing 1 - 20 results of 159 for search '"therapeutics"', query time: 0.14s Refine Results
  1. 1

    Myostatin: a potential therapeutic target for metabolic syndrome by Ming Yang, Ming Yang, Chongbin Liu, Chongbin Liu, Na Jiang, Na Jiang, Yan Liu, Yan Liu, Shilu Luo, Shilu Luo, Chenrui Li, Chenrui Li, Hao Zhao, Hao Zhao, Yachun Han, Yachun Han, Wei Chen, Wei Chen, Li Li, Li Li, Li Xiao, Li Xiao, Lin Sun, Lin Sun

    Published 2023-05-01
    “…Multiple studies have shown that myostatin (MSTN), a member of the TGF-β family, is involved in the development and development of obesity, hyperlipidemia, diabetes, and hypertension (clinical manifestations of metabolic syndrome), and thus may be a potential therapeutic target for metabolic syndrome. In this review, we describe the transcriptional regulation and receptor binding pathway of MSTN, then introduce the role of MSTN in regulating mitochondrial function and autophagy, review the research progress of MSTN in metabolic syndrome. …”
    Get full text
    Article
  2. 2
  3. 3

    Targeting iron-metabolism:a potential therapeutic strategy for pulmonary fibrosis by Yi Sun, Yu Ren, Li-yun Song, Yin-ying Wang, Tian-gang Li, Ying-li Wu, Li Li, Zhong-shan Yang

    Published 2024-03-01
    “…Targeting iron metabolism may be a potential therapeutic strategy for the prevention and treatment of pulmonary fibrosis.…”
    Get full text
    Article
  4. 4
  5. 5

    The NLRP3 inflammasome is a potential mechanism and therapeutic target for perioperative neurocognitive disorders by Jiayue Li, Li Li, Jiannan He, Jianhong Xu, Fangping Bao, Fangping Bao

    Published 2023-01-01
    “…The present review summarizes recent studies and systematically describes the pathogenesis of NLRP3 activation and regulation and potential therapeutics targeting NLRP3 inflammasomes in PNDs patients.…”
    Get full text
    Article
  6. 6

    Targeting interleukin 4 and interleukin 13: a novel therapeutic approach in bullous pemphigoid by Fangyuan Chen, Yiman Wang, Xinyi Chen, Nan Yang, Li Li

    Published 2023-12-01
    “…However, before this novel therapy can be approved for regular usage, further studies are needed concerning the long-term safety and systemic usage of IL-4/13 monoclonal antibody treatment in BP.KEY MESSAGESBP is an autoimmune skin disease with Th2-mediated autoimmune response involvement.As typical Th2 cytokines, IL-4 and IL-13 may contribute to the pathogenesis of BP in multiple ways, such as promoting Th2 cell polarization, driving the immunoglobulin class switching, recruiting eosinophils and basophils, and inducing pruritus.As a promising therapeutic approach for BP, IL-4/13 antagonists have shown satisfactory outcomes in preliminary clinical studies.…”
    Get full text
    Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    ARID1A deficiency promotes progression and potentiates therapeutic antitumour immunity in hepatitis B virus-related hepatocellular carcinoma by Tao Xing, Li Li, Xiaosong Rao, Jing Zhao, Yiran Chen, Gaoda Ju, Yaping Xu, Xuan Gao, Guilan Dong, Xuefeng Xia, Yanfang Guan, Lingling Zhang, Zhenping Wen, Jun Liang

    Published 2024-01-01
    “…Abstract Background Exploring predictive biomarkers and therapeutic strategies of ICBs has become an urgent need in clinical practice. …”
    Get full text
    Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20